Medeon Biodesign, Inc. (TPEX:6499)
72.00
-1.00 (-1.37%)
Sep 8, 2026, 1:30 PM CST
Medeon Biodesign Market Cap
Medeon Biodesign has a market cap or net worth of 7.06 billion as of September 8, 2026. Its market cap has decreased by -21.76% in one year.
Market Cap
7.06B
Enterprise Value
6.29B
Revenue
428.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
72.00
ChartMarket Cap Chart
Since December 11, 2014, Medeon Biodesign's market cap has increased from 5.77B to 7.06B, an increase of 22.33%. That is a compound annual growth rate of 1.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 7.06B | -19.04% |
| Dec 31, 2025 | 8.72B | 138.60% |
| Dec 31, 2024 | 3.65B | -14.91% |
| Dec 29, 2023 | 4.29B | -15.67% |
| Dec 30, 2022 | 5.09B | -22.76% |
| Dec 30, 2021 | 6.59B | 80.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Visco Vision | 14.46B |
| Vizionfocus | 12.25B |
| Bioteque | 7.83B |
| Pacific Hospital Supply | 5.66B |
| Formosa Optical Technology | 5.50B |
| St.Shine Optical | 4.97B |
| Bionime | 4.53B |
| ICARES Medicus | 3.67B |